Product Name | MF | CAS | Details |
---|
Upadacitinib Impurity | Details |
N,N'-DINITROSOPIPERAZINE | C4H8N4O2 | 140-79-4 | Details |
METHYL (2S,4S)-1-(TERT-BUTOXYCARBONYL)-4-METHYLPYROGLUTAMATE | C12H19NO5 | 196394-48-6 | Details |
Ergoline-8-methanol, 10-hydroxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8β)- | C23H24BrN3O3 | 57935-66-7 | Details |
Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8α)- | C24H26BrN3O3 | 58001-19-7 | Details |
Benzamide, 4-bromo-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)- | C26H24BrN5O7S | 2180923-65-1 | Details |
Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, ethyl ester, (1R,4S)- | C12H20O4S | 1242184-36-6 | Details |
Methyl (2S)-1-(tert-butoxycarbonyl)-4,4-dimethylpyroglutamate | C13H21NO5 | 158392-74-6 | Details |
S-(-)-Tolterodine | C22H31NO | 124937-53-7 | Details |
Deucravacitinib Impurity 12 | 2417138-48-6 | Details |
Nicergoline-5-Chloro Analogue | C24H26ClN3O3 | 38536-28-6 | Details |
Gimeracil Impurity | C8H9ClN2O3 | 17902-24-8 | Details |
C21H26BrNO4 | 916045-21-1 | Details |
(1R,2S,3R,4S)-3-((4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)carbamoyl)bicyclo [2.2.1]heptane-2-carboxylic acid | C21H31N5O3 | 2946602-47-5 | Details |
3-(2-Methoxy-5-methylphenyl)-3-phenyl propanol | C17H20O2 | 124937-73-1 | Details |
Dexpanthenol Impurity | C6H12O4 | 1112-32-9 | Details |
Azilsartan Impurity | C24H22N4O4 | 1397836-49-5 | Details |
Regorafenib Impurity 6 | C20H12ClF4N3O4 | 1187945-05-6 | Details |
Nifuratel impurity | C6H5N3O4 | 167103-07-3 | Details |
Glycerol Phenylbutyrate Impurity | C12H9I2N | 2204245-78-1 | Details |
Pyridinium, 5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-3-hydroxy-1-methyl- | 2414049-88-8 | Details |
Clemastine fumarate iMpurity | Details |
Azilsartan Impurity | C23H16N4O5 | 1442400-68-1 | Details |
Ergoline-8-methanol, 10-methoxy-1-methyl-, 5-bromo-3-pyridinecarboxylate (ester), (8β)- (9CI) | C23H24BrN3O3 | 192504-81-7 | Details |
C24H30N2O2 | 179915-79-8 | Details |
C20H18ClF2N3O4S | 2256739-25-8 | Details |
2-(3-Hydroxy-1-phenylpropyl)-4-methylphenol | C16H18O2 | 851789-43-0 | Details |
NA | 2289374-15-6 | Details |
4-(4-(5,5-Dimethyl-4,5-dihydrothiazol-2-yl)piperazin-1-yl)-6-isopropylthieno[2,3-d]pyrimidine | C18H25N5S2 | 1271738-59-0 | Details |
N-P-TOSYLGLYCINE BENZYL ESTER | C16H17NO4S | 63366-76-7 | Details |
Cyclohexanamine, 4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]-, cis- | C18H27Cl2N3 | 1480744-31-7 | Details |
Upadacitinib Impurity | C29H31N5O5S | 2270173-63-0 | Details |
3-Pyridazinecarboxylic acid, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]- | C19H19N7O4 | 2245111-18-4 | Details |
α-[(2-Chloroacetyl)[3-chloro-4-(2-propyn-1-yloxy)phenyl]amino]-N-(2-phenylethyl)-2-thiopheneacetamide | C25H22Cl2N2O3S | 2883115-46-4 | Details |
1-nitrosopiperazine | C4H9N3O | 5632-47-3 | Details |
4-(4-Bromo-butyl)-4-aza-tricyclo[5.2.1.02,6]decane-3,5-dione | C13H18BrNO2 | 99095-09-7 | Details |
2-Iodo-N-phenylaniline | C12H10IN | 61613-21-6 | Details |
Imidazo[1,2-a]pyrimidine, 7-chloro-5-methyl- | C7H6ClN3 | 2681279-09-2 | Details |
4-Chlor-3-nitro-5-sulfobenzoesure | C7H4ClNO7S | 130262-91-8 | Details |
Xanthine Impurity | Details |
rac Desisopropyl Tolterodine | C19H25NO | 480432-14-2 | Details |
DEESZEDZRHEUOI-UHFFFAOYSA-N | C13H22O4S | 1242184-40-2 | Details |
Ethyl diethoxyphosphinylformate | C7H15O5P | 1474-78-8 | Details |
Tolterodine EP Impurity G | C22H32NO2+ | 1554029-91-2 | Details |
(6bS,10aR)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline | C14H19N3 | 2339904-91-3 | Details |
6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-5-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide | C20H19D3N8O3 | 1609393-55-6 | Details |
racDidesisopropyl Tolterodine | C16H19NO | 1189501-90-3 | Details |
Ivabradine Impurity | C26H34N2O5 | 304462-60-0 | Details |
2H-Indazol-6-amine, N,2,3-trimethyl- | C10H13N3 | 1376676-65-1 | Details |
C9H8N4O3 | 1609394-05-9 | Details |
3-(2-methoxy-3-nitrophenyl)-1-methyl-1H-1,2,4-triazole | C10H10N4O3 | 1609394-08-2 | Details |
DCINQANYMBYYCH-UHFFFAOYSA-N | C16H21NO2 | 16052-33-8 | Details |
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride | C8H18ClN3 | 25952-53-8 | Details |
Fosfomycin iMpurity | C3H7O4P | 23155-02-4 | Details |
C12H19NO5 | 196394-49-7 | Details |
Midecamycin Acetate | C45H71NO17 | 55881-07-7 | Details |
N-(3-hydroxyphenyl)-N-(p-tolyl)nitrous amide | C13H12N2O2 | 497930-24-2 | Details |
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) | C8H11N3O6 | 39925-19-4 | Details |
tert-butyl(2-chloroethoxy)diMethylsilane | C8H19ClOSi | 89031-81-2 | Details |
9-ethyl-6,6-dimethyl-10-(4-morpholinopiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile | C30H34N4O2 | 1256584-79-8 | Details |
C7H3Cl2NO6S | 22892-95-1 | Details |
L-Phenylalanine, 4-borono-, 1-(1,1-dimethylethyl) ester | C13H20BNO4 | 1207346-27-7 | Details |
3-Pyridazinecarboxamide, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1H-1,2,4-triazol-5-yl)phenyl]amino]-N-(methyl-d3)- | C19H20N8O3 | 1609393-48-7 | Details |
3-Pyridazinecarboxylic acid, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-, zinc salt (2:1) | C19H19N7O4Zn | 2245111-19-5 | Details |
C27H37NO5 | 124935-89-3 | Details |
NA | 2760608-44-2 | Details |
Pseudo Acarbose | C25H43NO17 | 196944-81-7 | Details |
Acarbose EP Impurity G | C31H53NO23 | 1013621-73-2 | Details |
Foscarnet sodium hexahydrate EP Impurity A | C3H8NaO5P | 72305-00-1 | Details |
2-methoxy-3-(1-methyl-1H-1,2,4-triazol-5-yl)aniline | C10H12N4O | 2222717-52-2 | Details |
C16H16ClN7O2 | 1609394-23-1 | Details |
C20H18ClF2N3O4S | 2243786-07-2 | Details |
N-Nitroso Salmeterol | 3036581-81-1 | Details |
N-[(1R)-3-Hydroxy-1-methylpropyl]acetamide | C6H13NO2 | 1841458-79-4 | Details |
1H-Imidazole, 1-[2-(ethylsulfonyl)ethyl]-4-nitro- | C7H11N3O4S | 159790-77-9 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 |